Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01551953
Other study ID # 2010P000412
Secondary ID R01AT005436
Status Completed
Phase Phase 2
First received March 1, 2012
Last updated February 23, 2017
Start date February 2011
Est. completion date April 2016

Study information

Verified date February 2017
Source Beth Israel Deaconess Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main purpose of this study is to determine feasibility and effects of tai chi and mind-body breathing in patients with COPD.


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date April 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria:

1. Moderate-severe COPD

2. Age = 40 years

Exclusion Criteria:

1. Subjects with respiratory failure or GOLD stage 4 who are unable to safely perform a 6 minute walk test or otherwise safely exercise as deemed by a physician.

2. COPD exacerbation requiring steroids, antibiotics, ED visit or hospitalization within the past 2 weeks unless physician deems subject at baseline

3. Planned major pulmonary intervention within the next 3 months

4. Hypoxemia on walk test or cardiopulmonary exercise test

5. Inability to ambulate due to vascular or other neuromuscular conditions that would preclude a walk test

6. Clinical signs of unstable cardiovascular disease

7. Severe cognitive dysfunction

8. Non-English speaking

9. Current active participation in pulmonary rehabilitation program or current regular practice of tai chi

10. Physician diagnosis of unstable/untreated clinical depression

11. History of lung cancer

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tai chi
12 week tai chi class
Mind-body breathing
12 week breathing class
Education
12 week education class

Locations

Country Name City State
United States Beth Israel Deaconess Medical Center Boston Massachusetts
United States VA Healthcare System Boston Massachusetts

Sponsors (3)

Lead Sponsor Collaborator
Beth Israel Deaconess Medical Center National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of tai chi intervention Willingness to participate, adherence, and safety 12 weeks
Secondary Change from baseline- Disease specific quality of life Chronic Respiratory Questionnaire baseline, 12 weeks, 24 weeks
Secondary Change from baseline- Exercise capacity six-minute walk distance, cardiopulmonary exercise testing baseline, 12 weeks, 24 weeks
Secondary Change from baseline- Dyspnea UCSD Shortness of Breath Questionnaire baseline, 12 weeks, 24 weeks
Secondary Change from baseline- Psychosocial well-being CES-D, Perceive Stress Scale, COPD Self-Efficacy Scale, Multidimensional Scale of Percieved Social Support baseline, 12 weeks, 24 weeks
Secondary Change from baseline- Pulmonary function Spirometry and lung volumes baseline, 12 weeks, 24 weeks
Secondary Change from baseline- Physical strength and flexibility Chair Sit and Reach, Chair Stand baseline, 12 weeks, 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT03282019 - Study of Long-term HFNC for COPD Patients With HOT N/A
Completed NCT05573464 - A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Phase 3
Recruiting NCT06040086 - Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations Phase 3
Not yet recruiting NCT06376994 - Multi-Center Clean Air Randomized Controlled Trial in COPD Phase 3
Completed NCT02797392 - Feasibility of a Preventive Program Against Lifestyle Related Diseases N/A
Completed NCT02926534 - Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan N/A
Completed NCT02728674 - Management of Patients With Respiratory Symptoms in Sweden N/A
Recruiting NCT02415478 - Bronchioscopic Lung Volume Reduction (BLVR) N/A
Completed NCT03487406 - Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) Phase 2
Completed NCT02774226 - Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02512510 - Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT02518139 - A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT02459080 - Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01908140 - Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT01893476 - A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management N/A
Withdrawn NCT01908933 - Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema Phase 3
Completed NCT01615484 - Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability N/A
Completed NCT01701869 - Microbiology & Immunology of the Chronically-inflamed Airway N/A
Recruiting NCT02527486 - Seoul National University Airway Registry N/A
Withdrawn NCT01377428 - Efficacy of Indacaterol 150 µg Versus Formoterol Phase 4